Post-approval studies (Phase 4)UnknownNCT03017872What this trial is testingDolutegravir and Darunavir Evaluation in Adults Failing TherapyWho this might be right forHIV Infections Kirby Institute 831
Large-scale testing (Phase 3)Looking for participantsNCT06203132What this trial is testingDORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 InfectionWho this might be right forHIV-1-infection ANRS, Emerging Infectious Diseases 610
Large-scale testing (Phase 3)Study completedNCT03446573What this trial is testingSwitch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)Who this might be right forHIV Infections ViiV Healthcare 743
Testing effectiveness (Phase 2)Study completedNCT03982277What this trial is testingSafety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral TherapyWho this might be right forTuberculosis Makerere University 130
Early research (Phase 1)Study completedNCT04827134What this trial is testingA Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult ParticipantsWho this might be right forHIV Infections ViiV Healthcare 33
Post-approval studies (Phase 4)Not Yet RecruitingNCT07110831What this trial is testingDisposition Kinetics of Dolutegravir Among People Living With HIV With Major Depression in NigeriaWho this might be right forDepressionHIV University of Ibadan 168
Not applicableUnknownNCT04901728What this trial is testingPatients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study)Who this might be right forHIV Infections University of Sussex 118
Large-scale testing (Phase 3)Study completedNCT05917509What this trial is testingEvaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral TherapyWho this might be right forHIV Infections ViiV Healthcare 171
Early research (Phase 1)Study completedNCT01827540What this trial is testingStudy of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of MidazolamWho this might be right forHIV-infection/AIDS Tobira Therapeutics, Inc. 20
Post-approval studies (Phase 4)Study completedNCT03314064What this trial is testingPhase 4 Study of Dolutegravir (DTG) in Russian FederationWho this might be right forInfection, Human Immunodeficiency VirusHIV Infections ViiV Healthcare 43
Early research (Phase 1)Study completedNCT00858455What this trial is testingEvaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572Who this might be right forHealthy Volunteer GlaxoSmithKline 16
Not applicableStudy completedNCT04133012What this trial is testingCartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing Dolutegravir and Associated Nucleoside / Nucleotide Reverse Transcriptase Inhibitors BackboneWho this might be right forHIV-1 Infection ANRS, Emerging Infectious Diseases 20
Large-scale testing (Phase 3)Ended earlyNCT03493568What this trial is testingSwitch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)Who this might be right forHIV-1-infection IRCCS San Raffaele 100
Early research (Phase 1)Study completedNCT02082808What this trial is testingStudy to Evaluate the Drug Interaction Between Dolutegravir (DTG) and Daclatasvir (DCV) in Healthy Adult SubjectsWho this might be right forInfection, Human Immunodeficiency Virus ViiV Healthcare 12
Early research (Phase 1)Study completedNCT00774735What this trial is testingGSK1349572 Drug Interaction Study With Protease InhibitorsWho this might be right forHealthy SubjectsInfection, Human Immunodeficiency Virus GlaxoSmithKline 30
Post-approval studies (Phase 4)UnknownNCT04903847What this trial is testingChanges in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir DisproxilWho this might be right forHivHIV InfectionsHIV Lipodystrophy+4 more Thomas Benfield 126
Post-approval studies (Phase 4)Study completedNCT02487706What this trial is testingAssessment of Dolutegravir Removed by Hemodialysis in HIV-infected Patients With End-stage Renal DiseaseWho this might be right forHIV Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 5
Post-approval studies (Phase 4)UnknownNCT04295460What this trial is testingTriple vs. Double Therapy in naïves HIV-Infected PatientsWho this might be right forHIV Infection Hospitales Universitarios Virgen del Rocío 70
Post-approval studies (Phase 4)Looking for participantsNCT07616739What this trial is testingDolutegravir/Lamivudine in Treatment-Naïve Pregnant WomenWho this might be right forHIV-1-infection Fundación Huésped 210
Not applicableStudy completedNCT04568239What this trial is testingImpact of M184V on the Virological Efficacy to 3TC/DTG (LAMRES)Who this might be right forHIV-1-infection Association de Recherche en Virologie et Dermatologie 712